Cardiovascular disease and hypertension are strong risk factors for choroidal neovascularization.

PubWeight™: 1.26‹?› | Rank: Top 10%

🔗 View Article (PMID 17953990)

Published in Ophthalmology on October 22, 2007

Authors

Ruth E Hogg1, Jayne V Woodside, Sarah E C M Gilchrist, Ryan Graydon, Astrid E Fletcher, Wing Chan, Angela Knox, Barry Cartmill, Usha Chakravarthy

Author Affiliations

1: Centre for Vision Sciences, Belfast, United Kingdom.

Articles citing this

Age-related macular degeneration. Lancet (2008) 3.34

Relationship between RPE and choriocapillaris in age-related macular degeneration. Invest Ophthalmol Vis Sci (2009) 2.40

Clinical risk factors for age-related macular degeneration: a systematic review and meta-analysis. BMC Ophthalmol (2010) 2.32

Associations between abnormal rod-mediated dark adaptation and health and functioning in older adults with normal macular health. Invest Ophthalmol Vis Sci (2014) 1.65

Association of risk factors for choroidal neovascularization in age-related macular degeneration with decreased foveolar choroidal circulation. Am J Ophthalmol (2010) 1.47

Serum lipid biomarkers and hepatic lipase gene associations with age-related macular degeneration. Ophthalmology (2010) 1.29

Markers of inflammation, oxidative stress, and endothelial dysfunction and the 20-year cumulative incidence of early age-related macular degeneration: the Beaver Dam Eye Study. JAMA Ophthalmol (2014) 1.17

Lipids, lipoproteins, and age-related macular degeneration. J Lipids (2011) 1.05

VEGF receptor blockade markedly reduces retinal microglia/macrophage infiltration into laser-induced CNV. PLoS One (2013) 1.01

Elevated high-density lipoprotein cholesterol and age-related macular degeneration: the Alienor study. PLoS One (2014) 0.99

Age-related macular degeneration and the aging eye. Clin Interv Aging (2008) 0.96

Relationship between complement membrane attack complex, chemokine (C-C motif) ligand 2 (CCL2) and vascular endothelial growth factor in mouse model of laser-induced choroidal neovascularization. J Biol Chem (2011) 0.96

Age-related macular degeneration and incident cardiovascular disease: the Multi-Ethnic Study of Atherosclerosis. Ophthalmology (2011) 0.87

Age-Related Macular Degeneration: Advances in Management and Diagnosis. J Clin Med (2015) 0.87

PPARgamma Agonists: Potential as Therapeutics for Neovascular Retinopathies. PPAR Res (2008) 0.86

Polypoidal Choroidal Vasculopathy in Asians. J Clin Med (2015) 0.84

Age-related macular degeneration and the incidence of cardiovascular disease: a systematic review and meta-analysis. PLoS One (2014) 0.83

Alterations in Circulating Immune Cells in Neovascular Age-Related Macular Degeneration. Sci Rep (2015) 0.83

The reduction of serum soluble Flt-1 in patients with neovascular age-related macular degeneration. Am J Ophthalmol (2014) 0.82

Higher plasma levels of complement C3a, C4a and C5a increase the risk of subretinal fibrosis in neovascular age-related macular degeneration: Complement activation in AMD. Immun Ageing (2016) 0.81

Risk factors for exudative age-related macular degeneration in a large French case-control study. Graefes Arch Clin Exp Ophthalmol (2013) 0.80

Identifying subtypes of patients with neovascular age-related macular degeneration by genotypic and cardiovascular risk characteristics. BMC Med Genet (2011) 0.78

Angiotensin II-related hypertension and eye diseases. World J Cardiol (2014) 0.78

Effect of intravitreal anti-vascular endothelial growth factor therapy on the risk of arterial thromboembolic events: a meta-analysis. PLoS One (2012) 0.78

The Association between the Lipids Levels in Blood and Risk of Age-Related Macular Degeneration. Nutrients (2016) 0.77

In patients with neovascular age-related macular degeneration, physical activity may influence C-reactive protein levels. Clin Ophthalmol (2013) 0.77

Age-Related Macular Degeneration and Incident Stroke: A Systematic Review and Meta-Analysis. PLoS One (2015) 0.77

Iris color and associated pathological ocular complications: a review of epidemiologic studies. Int J Ophthalmol (2014) 0.76

Cross Sectional and Longitudinal Associations between Cardiovascular Risk Factors and Age Related Macular Degeneration in the EPIC-Norfolk Eye Study. PLoS One (2015) 0.76

Intake of dietary salt and drinking water: Implications for the development of age-related macular degeneration. Mol Vis (2016) 0.76

A novel endothelial-derived anti-inflammatory activity significantly inhibits spontaneous choroidal neovascularisation in a mouse model. Vasc Cell (2016) 0.75

Peripheral blood mononuclear cells from neovascular age-related macular degeneration patients produce higher levels of chemokines CCL2 (MCP-1) and CXCL8 (IL-8). J Neuroinflammation (2017) 0.75

Systemic, Ocular and Genetic Risk Factors for Age-related Macular Degeneration and Polypoidal Choroidal Vasculopathy in Singaporeans. Sci Rep (2017) 0.75

An association between environmental factors and the IVS4+44C>A polymorphism of the DMT1 gene in age-related macular degeneration. Graefes Arch Clin Exp Ophthalmol (2012) 0.75

Carboxyethylpyrrole plasma biomarkers in age-related macular degeneration. Drugs Future (2011) 0.75

Role of Lipids in Retinal Vascular and Macular Disorders. Indian J Clin Biochem (2016) 0.75

Visual and Morphologic Outcomes in Eyes with Hard Exudate in the Comparison of Age-Related Macular Degeneration Treatments Trials. Ophthalmol Retina (2017) 0.75

The relationship between vascular endothelial dysfunction and treatment frequency in neovascular age-related macular degeneration. Jpn J Ophthalmol (2017) 0.75

Articles by these authors

Treatment of hypertension in patients 80 years of age or older. N Engl J Med (2008) 21.04

Ranibizumab versus bevacizumab to treat neovascular age-related macular degeneration: one-year findings from the IVAN randomized trial. Ophthalmology (2012) 4.70

A common CFH haplotype, with deletion of CFHR1 and CFHR3, is associated with lower risk of age-related macular degeneration. Nat Genet (2006) 3.96

Clinical classification of age-related macular degeneration. Ophthalmology (2013) 2.92

The association between complement component 2/complement factor B polymorphisms and age-related macular degeneration: a HuGE review and meta-analysis. Am J Epidemiol (2012) 2.87

Prevalence of age-related maculopathy in older Europeans: the European Eye Study (EUREYE). Arch Ophthalmol (2006) 2.82

Reduced hearing, ownership, and use of hearing aids in elderly people in the UK--the MRC Trial of the Assessment and Management of Older People in the Community: a cross-sectional survey. Lancet (2002) 2.54

The natural history and prognosis of neovascular age-related macular degeneration: a systematic review of the literature and meta-analysis. Ophthalmology (2007) 2.46

Effect of 2-y n-3 long-chain polyunsaturated fatty acid supplementation on cognitive function in older people: a randomized, double-blind, controlled trial. Am J Clin Nutr (2010) 2.20

Weight, shape, and mortality risk in older persons: elevated waist-hip ratio, not high body mass index, is associated with a greater risk of death. Am J Clin Nutr (2006) 2.19

The estimated prevalence and incidence of late stage age related macular degeneration in the UK. Br J Ophthalmol (2012) 2.02

Cause-specific mortality in old age in relation to body mass index in middle age and in old age: follow-up of the Whitehall cohort of male civil servants. Int J Epidemiol (2005) 1.98

Common variants near FRK/COL10A1 and VEGFA are associated with advanced age-related macular degeneration. Hum Mol Genet (2011) 1.98

Systemic safety of bevacizumab versus ranibizumab for neovascular age-related macular degeneration. Cochrane Database Syst Rev (2014) 1.95

Depression and anxiety in visually impaired older people. Ophthalmology (2007) 1.94

Effects of immediate versus delayed antihypertensive therapy on outcome in the Systolic Hypertension in Europe Trial. J Hypertens (2004) 1.87

CKD and mortality risk in older people: a community-based population study in the United Kingdom. Am J Kidney Dis (2009) 1.74

Age related macular degeneration. BMJ (2003) 1.72

New treatments for neovascular acute macular degeneration. BMJ (2007) 1.69

Correlation of increased vascular endothelial growth factor with neovascularization and permeability in ischemic central vein occlusion. Arch Ophthalmol (2002) 1.67

Dietary patterns and breast cancer risk: a systematic review and meta-analysis. Am J Clin Nutr (2010) 1.46

Systematic review and meta-analysis of the association between complement component 3 and age-related macular degeneration: a HuGE review and meta-analysis. Am J Epidemiol (2011) 1.42

Bevacizumab for the treatment of neovascular age related macular degeneration. BMJ (2010) 1.40

Guidelines for the design, conduct and reporting of human intervention studies to evaluate the health benefits of foods. Br J Nutr (2011) 1.35

Detecting chronic kidney disease in older people; what are the implications? Age Ageing (2007) 1.30

Validity of the Clock-Drawing Test as a screening tool for cognitive impairment in the elderly. Am J Epidemiol (2004) 1.30

Oily fish consumption, dietary docosahexaenoic acid and eicosapentaenoic acid intakes, and associations with neovascular age-related macular degeneration. Am J Clin Nutr (2008) 1.29

Improving the response rates to questionnaires. BMJ (2002) 1.28

Factors associated with depression in a representative sample of 14 217 people aged 75 and over in the United Kingdom: results from the MRC trial of assessment and management of older people in the community. Int J Geriatr Psychiatry (2003) 1.28

Neovascular age-related macular degeneration risk based on CFH, LOC387715/HTRA1, and smoking. PLoS Med (2007) 1.27

Patient decision to initiate therapy for osteoporosis: the influence of knowledge and beliefs. J Gen Intern Med (2008) 1.25

Sunlight exposure, antioxidants, and age-related macular degeneration. Arch Ophthalmol (2008) 1.21

Inflammation markers are associated with cardiovascular diseases risk in adolescents: the Young Hearts project 2000. J Adolesc Health (2010) 1.20

Variations in apolipoprotein E frequency with age in a pooled analysis of a large group of older people. Am J Epidemiol (2011) 1.19

Prevalence of cataract in an older population in India: the India study of age-related eye disease. Ophthalmology (2011) 1.19

Evidence of association of APOE with age-related macular degeneration: a pooled analysis of 15 studies. Hum Mutat (2011) 1.17

Age-related macular degeneration causing visual impairment in people 75 years or older in Britain: an add-on study to the Medical Research Council Trial of Assessment and Management of Older People in the Community. Ophthalmology (2004) 1.17

Vegetarian diets, low-meat diets and health: a review. Public Health Nutr (2012) 1.16

Heritability and genome-wide association study to assess genetic differences between advanced age-related macular degeneration subtypes. Ophthalmology (2012) 1.16

Visual impairment and quality of life in the older European population, the EUREYE study. Acta Ophthalmol (2009) 1.14

Complement factor H genetic variant and age-related macular degeneration: effect size, modifiers and relationship to disease subtype. Int J Epidemiol (2012) 1.12

Pharmacogenetic associations with vascular endothelial growth factor inhibition in participants with neovascular age-related macular degeneration in the IVAN Study. Ophthalmology (2013) 1.11

Evidence for association of endothelial nitric oxide synthase gene in subjects with glaucoma and a history of migraine. Invest Ophthalmol Vis Sci (2005) 1.10

Psychophysical function in age-related maculopathy. Surv Ophthalmol (2009) 1.09

Dietary intake of fruits and vegetables improves microvascular function in hypertensive subjects in a dose-dependent manner. Circulation (2009) 1.07

Bilirubin and coronary heart disease risk in the Prospective Epidemiological Study of Myocardial Infarction (PRIME). Eur J Cardiovasc Prev Rehabil (2007) 1.07

EPHA2 polymorphisms and age-related cataract in India. PLoS One (2012) 1.06

Prevalence of early and late age-related macular degeneration in India: the INDEYE study. Invest Ophthalmol Vis Sci (2009) 1.05

Methods for a population-based study of the prevalence of and risk factors for age-related maculopathy and macular degeneration in elderly European populations: the EUREYE study. Ophthalmic Epidemiol (2004) 1.05

Further assessment of the complement component 2 and factor B region associated with age-related macular degeneration. Invest Ophthalmol Vis Sci (2008) 1.04

Prevalence of early and late age-related macular degeneration in a rural population in northern India: the INDEYE feasibility study. Invest Ophthalmol Vis Sci (2007) 1.03

Blood levels of vitamin C, carotenoids and retinol are inversely associated with cataract in a North Indian population. Invest Ophthalmol Vis Sci (2008) 1.03

AMD and micronutrient antioxidants. Curr Eye Res (2004) 1.02

Significant changes in dietary intake and supplement use after breast cancer diagnosis in a UK multicentre study. Breast Cancer Res Treat (2011) 1.02

Are older people dying of depression? Findings from the Medical Research Council trial of the assessment and management of older people in the community. J Am Geriatr Soc (2005) 1.01

The stromal cell marker SPARC predicts for survival in patients with diffuse large B-cell lymphoma treated with rituximab. Am J Clin Pathol (2011) 1.00

Secondary outcomes in a clinical trial of carotenoids with coantioxidants versus placebo in early age-related macular degeneration. Ophthalmology (2012) 1.00

A common insertion/deletion polymorphism of the thymidylate synthase (TYMS) gene is a determinant of red blood cell folate and homocysteine concentrations. Hum Genet (2005) 0.99

Do phytoestrogens reduce the risk of breast cancer and breast cancer recurrence? What clinicians need to know. Eur J Cancer (2008) 0.98

A randomised controlled trial investigating the effect of vitamin B12 supplementation on neurological function in healthy older people: the Older People and Enhanced Neurological function (OPEN) study protocol [ISRCTN54195799]. Nutr J (2011) 0.98

Fundus autofluorescence in age-related macular degeneration: an epiphenomenon? Invest Ophthalmol Vis Sci (2006) 0.97

Whole grains and health: attitudes to whole grains against a prevailing background of increased marketing and promotion. Public Health Nutr (2012) 0.96

Investigation of the BRAF V600E mutation by pyrosequencing in lymphoproliferative disorders. Am J Clin Pathol (2012) 0.95

Is the NEI-VFQ-25 a useful tool in identifying visual impairment in an elderly population? BMC Ophthalmol (2006) 0.95

Cytoplasmic ACK1 interaction with multiple receptor tyrosine kinases is mediated by Grb2: an analysis of ACK1 effects on Axl signaling. J Biol Chem (2009) 0.94

Biomarkers of fruit and vegetable intake in human intervention studies: a systematic review. Crit Rev Food Sci Nutr (2011) 0.94

Cause-specific visual impairment and mortality: results from a population-based study of older people in the United Kingdom. Arch Ophthalmol (2005) 0.94

The reduced folate carrier (SLC19A1) c.80G>A polymorphism is associated with red cell folate concentrations among women. Ann Hum Genet (2009) 0.94

Associations between chronic kidney disease and age-related macular degeneration. Ophthalmic Epidemiol (2009) 0.94

DNA-based eye colour prediction across Europe with the IrisPlex system. Forensic Sci Int Genet (2011) 0.94

Vitamin C is associated with reduced risk of cataract in a Mediterranean population. J Nutr (2002) 0.93

Trends in influenza vaccination uptake among people aged over 74 years, 1997-2000: survey of 73 general practices in Britain. BMC Fam Pract (2004) 0.93

Grading of age-related maculopathy for epidemiological studies: is digital imaging as good as 35-mm film? Ophthalmology (2003) 0.93

An insertion/deletion polymorphism of the dihydrofolate reductase (DHFR) gene is associated with serum and red blood cell folate concentrations in women. Hum Genet (2008) 0.93

A posteriori dietary patterns are related to risk of type 2 diabetes: findings from a systematic review and meta-analysis. J Acad Nutr Diet (2014) 0.93

Association of quality of life in old age in Britain with socioeconomic position: baseline data from a randomised controlled trial. J Epidemiol Community Health (2004) 0.93

Prevalence of lens opacities in North India: the INDEYE feasibility study. Invest Ophthalmol Vis Sci (2007) 0.93

Associations between aspirin use and aging macula disorder: the European Eye Study. Ophthalmology (2011) 0.93

Homocysteine, methylenetetrahydrofolate reductase C677T polymorphism, and risk of retinal vein occlusion: a meta-analysis. Ophthalmology (2009) 0.93

Increasing use of a new health technology during the wait for NICE guidance: findings from the third national tracker survey of photodynamic therapy. J Public Health (Oxf) (2004) 0.92

Economic burden of gouty arthritis attacks for employees with frequent and infrequent attacks. Popul Health Manag (2012) 0.92

Distortion maps from preferential hyperacuity perimetry are helpful in monitoring functional response to Lucentis therapy. Retina (2009) 0.92

Barriers to increasing fruit and vegetable intakes in the older population of Northern Ireland: low levels of liking and low awareness of current recommendations. Public Health Nutr (2010) 0.91

Prevalence and risk factors for vitamin C deficiency in north and south India: a two centre population based study in people aged 60 years and over. PLoS One (2011) 0.91

Terminal digit preference and single-number preference in the Syst-Eur trial: influence of quality control. Blood Press Monit (2002) 0.91